Stay updated on Pomalidomide Combo for RRMM Clinical Trial
Sign up to get notified when there's something new on the Pomalidomide Combo for RRMM Clinical Trial page.

Latest updates to the Pomalidomide Combo for RRMM Clinical Trial page
- Check5 days agoChange DetectedA banner announces an NIH website transition and says that NIH content may use “Super Intelligence” alongside “Artificial Intelligence” during the transition.SummaryDifference1%

- Check12 days agoChange DetectedThe footer revision number changes from v3.7.1 to v3.7.2, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check19 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check40 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study content with an access-denied message. This indicates the record is currently inaccessible rather than providing the study details.SummaryDifference20%

- Check61 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6, indicating a newer version of the study details page. This update reflects changes to the page since the previous revision.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page removes the disease name 'Multiple myeloma' and the related topics entry 'MedlinePlus Genetics' from the related topics section. This changes how readers understand the study's focus and the linked resources.SummaryDifference0.1%

Stay in the know with updates to Pomalidomide Combo for RRMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pomalidomide Combo for RRMM Clinical Trial page.